Lionsgate has rejected Carl Icahn's sweetened offer for the minimajor, a week after the activist investor raised his hostile bid by 17%.
Amping up the pressure on Lionsgate, Carl Icahn has raised his hostile offer for the company to $7 a share, a 17% increase.
Carl Icahn has raised his hostile offer for Lionsgate to $7 a share, a 17% increase.
Domestic Film DAILY
PROVIDED BY: Box Office
The Equalizer1Daily:$3.6M Cumulative:$40.7M Sony / Columbia 22.26%
The Maze Runner
The Maze Runner2Daily:$1.3M Cumulative:$60.2M Fox 29.30%
The Boxtrolls3Daily:$862,914 Cumulative:$18.9M Focus 17.65%
Lionsgate and Carl Icahn are ramping up their battle for control of the minimajor, with both sides campaigning over Lionsgate's proposed "poison pill" provision.
Thanks to Carl Icahn, Lionsgate toppers Jon Feltheimer and Michael Burns find themselves in the spotlight these days.
Saban Capital Group is partnering with Lionsgate on a plan to expand Lionsgate's Tiger Gate pay TV business in Asia.
Lionsgate is urging its shareholders to enact a poison pill provision that would make it far more difficult for Carl Icahn's hostile takeover to succeed.
When Carl Icahn bumped up his investment in Lionsgate to 9% in October 2008, Lionsgate spokesman Peter Wilkes told a reporter, "We welcome his input, which is always very perceptive. He has a great…
Lionsgate's reportedly pulling the plug on its efforts to buy MGM, leaving only Time Warner Inc. and Access Industries as bidders for the beleagurered studio.
The battle between Lionsgate and Carl Icahn has entered the trench warfare stage with both sides blasting each other on a daily basis.